Improve patient and caregiver engagement for post hematopoietic cell transplant patients
Hematopoietic stem cell transplant recipients represent a highly complex patient cohort because of potential complications, increased mortality, lengthy rehabilitation, compromised immune function, and the overall complexity and risk associated with the procedure. The first 100 days post-transplant represent a critical period for patient follow-up. Continue reading to learn about innovative ways you can improve patient and caregiver engagement post-transplant.
The importance of education and communication
The informational and educational needs for both the patient and the caregiver are significant as the care setting shifts from the transplant center to the home. The ability to recognize and report signs and symptoms of potential complications to the patient’s care team is essential and requires a high level of patient engagement. Studies have shown that increased patient engagement—patients actively participating in their care—can result in higher satisfaction, improved outcomes, and lower costs.
Enabling innovative patient self-management
When focusing on hematopoietic cell transplant patient populations, information technology has been proven to play a key role in enhancing patient engagement. Patient portals supporting bi-directional communication can increase the ability of patients to self-manage their care through technology platforms to input and track health information, driving communication between patients and their care providers.
Available technologies
As patients continue to become more technologically savvy, and hospitals and medical practices invest in innovative tools to increase patient engagement, hematopoietic cell transplant patients can and will benefit from better and more accessible information technology.
Leveraging solution elements to simplify the communication between patient and caregiver opens the door for providing better outcomes.
- Secure, instant care team messaging
- Two-way communication
- HIPPA compliant video sessions
- Customizable forms and surveys
- Auto-escalation features
- Educational outreach
- Multi-lingual support
- EMR integration
Conclusion
The number of hematopoietic cell transplants performed in the United States and globally continues to increase both for malignant and non-malignant diseases involving the hematopoietic system and some solid tumors. The expanding use of novel cell and gene therapies is also contributing to the increase in procedure volume
Technologies to improve patient and caregiver engagement are not simply a courtesy to the patient. Higher engagement can lead to better outcomes.
To learn more, download our white paper: Improving patient and caregiver engagement post hematopoietic cell transplant.